The bisnaphthalimides as new active lead compounds against Plasmodium falciparum

Bioorganic and Medicinal Chemistry

Volumn 18, Issue 9, 2010, Pages 2998-3003

  Tischer, Maximilian ^a   Sologub, Ludmilla ^a   Pradel, Gabriele ^a   Holzgrabe, Ulrike ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Bisquaternary bisnaphthalimides; Malaria; Plasmodium falciparum

Indexed keywords

BISNAPHTHALIMIDE DERIVATIVE; NAPHTHALIMIDE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; CONCENTRATION (PARAMETERS); CYTOTOXICITY; DRUG DESIGN; DRUG MECHANISM; NONHUMAN; PLASMODIUM FALCIPARUM; QUALITATIVE ANALYSIS; STRUCTURE ACTIVITY RELATION;

ANIMALS; ANTIMALARIALS; CELL LINE; MACROPHAGES; MOLECULAR STRUCTURE; NAPHTHALIMIDES; PLASMODIUM FALCIPARUM; QUATERNARY AMMONIUM COMPOUNDS; STRUCTURE-ACTIVITY RELATIONSHIP;

PLASMODIUM FALCIPARUM;

EID: 77951205484     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmc.2010.03.067     Document Type: Article

References (26)

1. WHO Malaria Report 2009, World Health Organization, Geneve, Switzerland; http://apps.who.int/malaria/wmr2008 (last accessed Nov 18th, 2008).
2. Greenwood B.M., Fidock D.A., Kyle D.E., Kappe S.H., Alonso P.L., Collins F.H., and Duffy P.E. J. Clin. Invest. 118 (2008) 1266
3. Greenwood B.M., Bojang K., Whitty C.J.M., and Targett G.A.T. Malaria, Lancet 365 (2005) 1487
4. Calas M., Ancelin M.L., Cordina G., Portefaix P., Piquet G., Vidal-Sailhan V., and Vial H. J. Med. Chem. 43 (2000) 505
5. Vial H., and Ancelin M.L. Malarial Lipids Subcellu. Biochem. (1992) 259
6. Ancelin M.L., Parant M., Thuet M.J., Philippot J.R., and Vial H. Biochem. J. 273 (1991) 701
7. Hamzé A., Rubi E., Arnal P., Boisbrun M., Carcel C., Salom-Roig X., Maynadier M., Wein S., Vial H., and Calas M. J. Med. Chem. 48 (2005) 3639
8. Degardin M., Wein S., Durand T., Escale R., Vial H., and Vo-Hoang Y. Bioorg. Med. Chem. Lett. 19 (2009) 5233
9. Ortial S., Denoyelle S., Wein S., Berger O., Durand T., Escale R., Pellet A., Vial H., and Vo-Hoang Y. ChemMedChem 5 (2010) 52
10. Le Roch K.G., Johnson J.R., Ahiboh H., Chung D.-W.D., Prudhomme J., Plouffe D., Henson K., Zhou Y., Witola W., Yates J.R., Mamoun C.B., Winzeler E.A., and Vial H. BMC Genomics 9 (2008) 513
11. Alberge B., Gannoun-Zaki L., Bascunana C., Tran Wa Ba C., Vial H., and Cerdan R. Biochem. J. 425 (2010) 149
12. Brana M.F., and Ramos A. Curr. Med. Chem. Anticancer Agents 1 (2001) 237
13. Sami S.M., Dorr R.T., Alberts D.S., Solyom A.M., and Remers W.A. J. Med. Chem. 43 (2000) 3067
14. Muth M., Bender W., Scharfenstein O., Holzgrabe U., Balatkova E., Tränkle C., and Mohr K. J. Med. Chem. 46 (2003) 1031
15. Bender W., Staudt M., Tränkle C., Mohr K., and Holzgrabe U. Life Sci. 46 (2000) 1031
16. Muth M., Hoerr V., Glaser M., Ponte-Sucre A., Moll H., Stich A., and Holzgrabe U. Bioorg. Med. Chem. Lett. 17 (2007) 1590
17. Schmitz J., Heller E., and Holzgrabe U. Monatsh. Chem. 138 (2007) 171
18. Calas M., Cordina G., Bompart J., Bari M.B., Jei T., Ancelin M.L., and Vial H. J. Med. Chem. 40 (1997) 3557
19. Ifediba T., and Vanderberg J.P. Nature 294 (1981) 364
20. Makler M.T., and Hinrichs D.J. Am. J. Trop. Med. Hyg. 48 (1993) 205
21. Makler M.T., Ries J.M., Williams J.A., Bancroft J.E., Piper R.C., Gibbins L.B., and Hinrichs D.J. Am. J. Trop. Med. Hyg. 48 (1993) 739
22. Ahmed S.A., Gogal R.M., and Walsh J.E. J. Immunol. Methods 170 (1994) 211
23. Fuijimoto K., Morisaki D., Yoshida M., Namba T., Hye-Sook K., Wataya Y., Kourai H., Kakuta H., and Sasaki K. Bioorg. Med. Chem. Lett. 16 (2006) 2758
24. Calas M., Ouattara M., Piquet G., Ziora Z., Bordat Y., Ancelin M.L., Escale R., and Vial H. J. Med. Chem. 50 (2007) 6307
25. Motoshima K., Hiwasa Y., Yoshikawa M., Fuijimoto K., Tai A., Kakuta H., and Sasaki K. ChemMedChem 2 (2007) 1527
26. Burton A.W. J. Am. Chem. Soc. 129 (2007) 7627